These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12359081)

  • 21. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activities of 8-substituted 2-5A analogues.
    Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
    Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
    Williams GJ; De Benedetti A; Baglioni C
    Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives.
    Sobol RW; Henderson EE; Kon N; Shao J; Hitzges P; Mordechai E; Reichenbach NL; Charubala R; Schirmeister H; Pfleiderer W
    J Biol Chem; 1995 Mar; 270(11):5963-78. PubMed ID: 7890727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.
    Park IH; Kwon YC; Ryu WS; Ahn BY
    Antiviral Res; 2014 Apr; 104():118-27. PubMed ID: 24509240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.
    Rusch L; Dong B; Silverman RH
    Methods Enzymol; 2001; 342():10-20. PubMed ID: 11586885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.
    Imai J; Lesiak K; Torrence PF
    J Biol Chem; 1985 Feb; 260(3):1390-3. PubMed ID: 2981855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interferon-inducible recombinant human RNase L causes RNA degradation and inhibition of cell growth in Escherichia coli.
    Pandey M; Rath PC
    Biochem Biophys Res Commun; 2004 Apr; 317(2):586-97. PubMed ID: 15063798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
    Salehzada T; Silhol M; Steff AM; Lebleu B; Bisbal C
    J Biol Chem; 1993 Apr; 268(11):7733-40. PubMed ID: 8463302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
    Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
    EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
    Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.
    Malathi K; Paranjape JM; Ganapathi R; Silverman RH
    Cancer Res; 2004 Dec; 64(24):9144-51. PubMed ID: 15604285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purine 8-substitution modulates the ribonuclease L binding and activation abilities of 2',5'-oligoadenylates.
    Kanou M; Ohomori H; Nagai K; Yokoyama S; Suhadolnik RJ; Sobol R; Takaku H
    Biochem Biophys Res Commun; 1991 Apr; 176(2):769-74. PubMed ID: 2025289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 2-5A system in viral infection and apoptosis.
    Castelli J; Wood KA; Youle RJ
    Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleavage of oligoribonucleotides by the 2',5'-oligoadenylate- dependent ribonuclease L.
    Carroll SS; Chen E; Viscount T; Geib J; Sardana MK; Gehman J; Kuo LC
    J Biol Chem; 1996 Mar; 271(9):4988-92. PubMed ID: 8617774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L.
    Cramer H; Geselowitz DA; Torrence PF
    Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.
    Verheijen JC; van der Marel GA; van Boom JH; Bayly SF; Player MR; Torrence PF
    Bioorg Med Chem; 1999 Mar; 7(3):449-55. PubMed ID: 10220031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of double-stranded-RNA-specific RNase III of Escherichia coli is lethal to Saccharomyces cerevisiae.
    Pines O; Yoon HJ; Inouye M
    J Bacteriol; 1988 Jul; 170(7):2989-93. PubMed ID: 3290193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.